Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» grazoprevir/elbasvir
grazoprevir/elbasvir
Is Merck & Co. About to Derail Gilead Sciences?
Motley Fool
Tue, 12/22/15 - 09:59 pm
Merck
Gilead Sciences
grazoprevir/elbasvir
Viekira Pak
AbbVie
Merck Will Soon See a Decision on Its New Hepatitis C Therapy
Yahoo/Market Realist
Thu, 12/17/15 - 01:52 pm
Merck
hepatitis C
grazoprevir/elbasvir
Is Merck & Co A Bigger-Than-Expected Threat To Gilead Sciences In HCV?
Bidness, ETC
Mon, 11/16/15 - 03:36 pm
Merck
Gilead Sciences
hepatitis C
MK-3682
grazoprevir/elbasvir
MK-8408
A Trio of Catalysts Lift Merck Higher in October
Motley Fool
Wed, 11/11/15 - 10:00 am
Merck
Keytruda
grazoprevir/elbasvir
hepatitis C
earnings
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Mon, 08/3/15 - 05:10 pm
Merck
Gilead Sciences
AbbVie
hepatitis C
Viekira Pak
Harvoni
Sovaldi
grazoprevir/elbasvir
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
Medical Marketing and Media
Wed, 07/29/15 - 09:46 pm
hepatitis C
Merck
grazoprevir/elbasvir
Gilead Sciences
Harvoni
Sovaldi
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Sat, 05/30/15 - 12:27 pm
Merck
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
grazoprevir/elbasvir
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Yahoo/Benzinga
Fri, 04/24/15 - 10:35 am
Biogen
Tecfidera
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
hepatitis C
Merck and Gilead square off in battle of the next-next-gen hep C combos
Fierce Biotech
Thu, 04/23/15 - 09:50 am
Merck
Gilead Sciences
hepatitis C
grazoprevir/elbasvir
GS-5816
GS-9857
Why Merck's Victory Is of Little Concern to Gilead
Investopedia
Sat, 04/11/15 - 10:27 am
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Sovaldi
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Wed, 04/8/15 - 12:05 pm
Merck
AbbVie
hepatitis C
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Merck's potential HCV drug gets special FDA designation
Yahoo/AP
Wed, 04/8/15 - 10:41 am
Merck
hepatitis C
FDA
grazoprevir/elbasvir